Wellington Management Group
GTHX

Wellington Management Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Wellington Management Group’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-102,836
Closed -$276K – 2051
2023
Q1 		$276K Sell
102,836
-2,568
-2% -$12.3K ﹤0.01% 1938
2022
Q4 		$572K Buy
105,404
+3,396
+3% +$28.5K ﹤0.01% 1783
2022
Q3 		$1.27M Buy
102,008
+19,794
+24% +$226K ﹤0.01% 1611
2022
Q2 		$406K Hold
82,214
– – ﹤0.01% 1882
2022
Q1 		$624K Sell
82,214
-10,864
-12% -$103K ﹤0.01% 1845
2021
Q4 		$950K Buy
+93,078
New +$1.19M ﹤0.01% 1813
2021
Q1 		– Sell
-1,237,342
Closed -$22.3M – 2203
2020
Q4 		$22.3M Sell
1,237,342
-1,749,487
-59% -$26.1M ﹤0.01% 1009
2020
Q3 		$34.5M Sell
2,986,829
-484,203
-14% -$7.99M 0.01% 800
2020
Q2 		$84.2M Sell
3,471,032
-249,337
-7% -$4.12M 0.02% 563
2020
Q1 		$41M Sell
3,720,369
-1,447,815
-28% -$27M 0.01% 691
2019
Q4 		$137M Sell
5,168,184
-19,389
-0.4% -$453K 0.03% 491
2019
Q3 		$118M Buy
5,187,573
+6,721
+0.1% +$212K 0.03% 505
2019
Q2 		$159M Buy
5,180,852
+544,378
+12% +$11.5M 0.04% 430
2019
Q1 		$77M Buy
4,636,474
+866,859
+23% +$16.4M 0.02% 614
2018
Q4 		$72.2M Buy
3,769,615
+560,428
+17% +$21M 0.02% 604
2018
Q3 		$168M Buy
3,209,187
+381,054
+13% +$20.8M 0.04% 434
2018
Q2 		$123M Buy
2,828,133
+190,485
+7% +$8.16M 0.03% 521
2018
Q1 		$97.7M Buy
2,637,648
+1,221,405
+86% +$32.6M 0.02% 580
2017
Q4 		$28.1M Buy
1,416,243
+574,154
+68% +$12.3M 0.01% 964
2017
Q3 		$21M Buy
842,089
+7,526
+0.9% +$139K ﹤0.01% 1033
2017
Q2 		$14.6M Buy
+834,563
New +$14.6M ﹤0.01% 1119

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group's GTHX Position: Q2 2023 in Review

Wellington Management Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2023, closing a stake of 102,836 shares — an estimated $276K sold.

Wellington Management Group first reported a position in GTHX in Q2 2017 and held it in 21 quarters. The position peaked at $168M in Q3 2018. 80 funds tracked by Wall St. Rank hold GTHX as of Q2 2023.

  • Wellington Management Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Wellington Management Group sold 102,836 G1 Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $276K.
  • Wellington Management Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 21 quarters.
  • Wellington Management Group's G1 Therapeutics, Inc. Common Stock position peaked at $168M in Q3 2018.
  • 80 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.